Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular snapshots of human polynucleotide phosphorylase (hPNPase) in action, ...
Maintaining long-term health has become a major challenge, driving research into ways to extend “healthspan” rather than ...
Our immune systems weaken as we get older, making fewer cells that fight infection and help us recover from illness and injury. Scientists aren't completely sure why. They may have a better idea now, ...
New research published in Brain, Behavior, and Immunity provides evidence that alcohol use disorder triggers a distinct type ...
Streamlined, automation-ready approaches help scientists reproducibly generate antibody data with high-yield HEK293 transient ...
Proteomic analysis reveals angiogenesis-related plasma proteins associated with pre-eclampsia in SLE
Objective Delivery of a small for gestational age (SGA) infant is a common pregnancy complication among women with SLE. Although disease activity and autoantibodies such as anti-Smith and ...
Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial to evaluate ARV-393 plus glofitamab as a ...
—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs) demonstrate durable seizure reductions, including increases in ...
As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...
CARMIEL, Israel, Sept. 2, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback